KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹394 Cr | ₹354 Cr | ₹341 Cr | ₹166 Cr | ₹132 Cr |
What is the latest Total Liabilities ratio of KWALITY PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹394 Cr |
Mar2023 | ₹354 Cr |
Mar2022 | ₹341 Cr |
Mar2021 | ₹166 Cr |
Mar2020 | ₹132 Cr |
How is Total Liabilities of KWALITY PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹394 Cr | 11.47 | |
Mar2023 | ₹354 Cr | 3.83 | |
Mar2022 | ₹341 Cr | 104.90 | |
Mar2021 | ₹166 Cr | 25.46 | |
Mar2020 | ₹132 Cr | - |
Compare Total Liabilities of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹905.0 Cr | 0.4% | 0.3% | 87.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,744.0 Cr | -4.2% | -7.7% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,209.0 Cr | -0.6% | -5.6% | 57.5% | Stock Analytics | |
CIPLA | ₹117,762.0 Cr | 3.3% | -4.8% | 6.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,705.3 Cr | -2.4% | -12.8% | 1.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,929.3 Cr | -0.3% | -2.1% | 24.5% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | 0.4% |
0.3% |
87.7% |
SENSEX | 0.3% |
-1.8% |
8.6% |
You may also like the below Video Courses